Telaprevir Experience From Turkey


KÖMÜR S. , KURTARAN B. , İNAL A. S. , PULLUKÇU H., ULU A. , Kuscu F. , ...Daha Fazla

HEPATITIS MONTHLY, cilt.15, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 15 Konu: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5812/hepatmon.25639
  • Dergi Adı: HEPATITIS MONTHLY

Özet

Background: In patients with chronic hepatitis C, triple drug regimens containing a protease inhibitor, peginterferon and ribavirin were found to significantly increase sustained virologic response rates compared to dual drug regimen containing pegylated interferon and ribavirin, especially in genotype 1.